Navigation Links
DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Pretrial Order in New Jersey DePuy ASR Recall Litigation
Date:8/7/2013

New York, New York (PRWEB) August 07, 2013

Lawsuits filed in the wake of the 2010 DePuy ASR recall (http://www.depuy-asr-hip-recall.com/) continue to move forward in a Multicounty Litigation now underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Pretrial Order issued on July 26th, the court has established deadlines for submission of proposed jury questionnaires, verdict forms and jury instructions for the litigation’s first bellwether trial. Among other things, the Order also stipulates that any motions for dismissal or summary judgment must be filed with the Court by September 17th. The Order sets a Pretrial Conference for October 8th, with the trial scheduled to get underway on October 21, 2013. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)

“We are representing hundreds of clients in DePuy ASR lawsuits. This trial, along with the bellwether trial scheduled to begin next month in the federal multidistrict litigation, are important steps forward in the litigation and could provide clues as to how juries might weigh evidence in similar cases,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Lawsuits
According to the U.S. Food & Drug Administration, a worldwide recall was announced in August 2010 for DePuy ASR hip implants, after the metal-on-metal devices were found to be failing prematurely in an unexpectedly high number of recipients. Since then, Johnson & Johnson and its DePu
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial
2. DePuy Pinnacle Hip Lawsuit Filings in Federal Multidistrict Litigation Exceed 4,600, Bernstein Liebhard LLP Reports
3. DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
4. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
5. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy Pinnacle Hip Litigation
6. US Drug Watchdog Now Urges All DePuy ASR Recalled Metal Hip Implant Recipients In The Remaining States To Call Them Immediately If They Have Not Yet Been Identified
7. US Drug Watchdog Now Warns Recipients Of A Recalled DePuy ASR Hip Implant About Statute Of Limitations Deadline To Get Identified And Urges Recipients To Call Them
8. California Judge Allows Plaintiffs in DePuy ASR Litigation to Combine DePuy Pinnacle Claims, Parker Waichman LLP Notes
9. DePuy Hip Replacement Lawsuit News: California Judge Allows DePuy ASR Lawsuit Plaintiffs to Add Pinnacle Hip Claims
10. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them About A Vital Blood Test That Should Reveal A Premature Failure
11. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them For The Name Of A Special Blood Test That Will Determine A Premature Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... Researchers have found that fecal transplantation is effective ... immunocompromised patients. This is the result of a study ... Center for Women,s Gastrointestinal Medicine at The Women,s Medicine ... online in advance of print in the American ... or C. diff , has increased to epidemic ...
(Date:7/9/2014)... news release is available in French . ... factors in 14 year old teens, including brain structure and ... 70% accuracy who will go on to develop binge drinking ... of conscientiousness, and other variables such as life events and ... of binge drinking. Whether or not the child had ...
(Date:7/9/2014)... is for more than watching World Cup highlights, Brian ... skateboarders landing in unfortunate positions on railings. A University ... Dermatology Online Journal shows that YouTube also allows ... the public on topics of skin cancer and prevention. ... is the future of how we communicate around the ...
(Date:7/9/2014)... 9, 2014) A retrospective study conducted by researchers ... reports that among adults with intellectual and developmental disabilities, ... of years receiving dental care increased. The findings, published ... Dentistry , may help improve interventions designed to address ... , The researchers reviewed the dental records of 107 ...
(Date:7/9/2014)... 9, 2014 A study published in the scientific ... and Robert Bonin, two researchers at Universit Laval, reveals ... a new method that involves rekindling pain so that ... to novel means to alleviate chronic pain. , The ... and Institut universitaire en sant mentale de Qubec (IUSMQ) ...
Breaking Medicine News(10 mins):Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:What drives a child to abuse alcohol? 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Discovery of a new means to erase pain 2
... productivity industry, WASHINGTON, March 31 The ... on Health (NBCH), two,nationally-recognized non-profit organizations focused on ... and quality of life, are,partnering to host the ... will take place February 9-11, 2009 at the ...
... of elderly patients could cut their total mortality by ... a third, according to a new study presented today ... in Chicago and published simultaneously in the New England ... the Very Elderly Trial (HYVET), which is coordinated by ...
... Chicago, IL, March 31, 2008 New data ... technology found that in patients living with type ... burden in the coronary arteries compared to glimepiride, ... data stem from the PERISCOPE (Pioglitazone Effect on ...
... DIEGO, March 31 Amira Pharmaceuticals, a small,molecule ... of,compounds to treat inflammatory disease, today announced the ... directors: Dennis M. Fenton, Ph.D.,and Stephen W. Kaldor, ... pharmaceutical and biotechnology experience,including over two decades at ...
... Focus on Delivering on ... 2008 Free Cash Flow Target, SIOUX ... the leading provider of media and,connectivity solutions to hospitality and healthcare ... Conference at The Palms,Hotel in Las Vegas on Wednesday, April 2. ...
... 31 Greenway Medical Technologies,announced today its expanded ... Quality Reporting Initiative (PQRI) and Pay for,Performance (P4P) ... technology (HIT) adoption., The PQRI, which was ... Medicare, Medicaid, and SCHIP Extension Act of 2007, ...
Cached Medicine News:Health News:Integrated Benefits Institute and National Business Coalition on Health to Host First Annual Health and Productivity Forum 2Health News:Significant reductions in mortality shown using blood pressure-lowering treatment in very elderly 2Health News:Significant reductions in mortality shown using blood pressure-lowering treatment in very elderly 3Health News:New data showed Actos prevented progression of atherosclerotic plaque volume in patients 2Health News:Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors 2Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 2Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 3Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 4Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 5Health News:Greenway Medical Technologies Expands Support for Physician Quality Reporting Initiative and Pay for Performance Programs 2Health News:Greenway Medical Technologies Expands Support for Physician Quality Reporting Initiative and Pay for Performance Programs 3Health News:Greenway Medical Technologies Expands Support for Physician Quality Reporting Initiative and Pay for Performance Programs 4
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... received commitments from institutional investors to purchase an aggregate ... in an at-the-market registered direct offering, led by a ... into definitive purchase agreements with these investors pursuant to ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... on study results demonstrating survival advantage ... months when added to standard therapy, -- First study ... BOULDER, Colo., Jan. 24 Pharmion Corporation,(Nasdaq: PHRM ) ... positive opinion to recommend approval of Thalidomide,Pharmion(R) for use in ...
... with Fractionated Lasers Or in ... the Eyes, WALTHAM, Mass., Jan. 24 When it ... no longer the only option. According to the,American Academy of ... who is interested in non-surgical options to obtain the,best results. ...
Cached Medicine Technology:Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 2Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 3Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 4Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 5Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 6Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes 2Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes 3Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes 4
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
... PVC. 2 eyes, oral. Marked with ... X-ray opaque line. Graduated. Single use. ... reduce kinking of the tube by ... adapts to the anatomical situation at ...
... Ruschelit® PVC. Murphy eye-oral. High volume/low ... Oral Cuffed Single use. For improved ... of the tube by incorporating a ... cuff. Thermosensitive Ruschelit® PVC adapts to ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. Murphy eye. High volume/low pressure cuff. Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Steri...
Medicine Products: